Vyne Therapeutics Inc (VYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,418 | 73,811 | 97,366 | 58,456 | 44,584 |
| Marketable Securities | 1,027 | 3,046 | 3,044 | 24,211 | 28,782 |
| Receivables | 15,819 | 11,189 | 10,407 | 8,333 | 135 |
| Inventories | 7,404 | 6,650 | 5,801 | 3,205 | 1,356 |
| TOTAL | $87,259 | $98,162 | $119,290 | $98,441 | $76,414 |
| Non-Current Assets | |||||
| PPE Net | 555 | 2,744 | 2,811 | 2,834 | 2,885 |
| Intangibles | 0 | 0 | 0 | 4,045 | 0 |
| Other Non-Current Assets | 5,928 | 6,777 | 8,741 | 55,213 | 1,860 |
| TOTAL | $6,483 | $9,521 | $11,552 | $62,092 | $4,745 |
| Total Assets | $93,742 | $107,683 | $130,842 | $160,533 | $81,159 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,780 | 4,622 | 9,952 | 14,114 | 19,352 |
| Accrued Expenses | 11,452 | 12,132 | 8,812 | 12,452 | 3,381 |
| Other current liabilities | 4,776 | 5,340 | 4,223 | 29,011 | 5,501 |
| TOTAL | $21,765 | $23,192 | $24,232 | $56,586 | $29,326 |
| Non-Current Liabilities | |||||
| Long Term Debt | 33,174 | 33,017 | 32,915 | 32,818 | 32,725 |
| Other Non-Current Liabilities | 1,310 | 1,958 | 2,167 | 1,594 | 1,533 |
| TOTAL | $34,484 | $34,975 | $35,082 | $34,412 | $34,258 |
| Total Liabilities | $56,249 | $58,167 | $59,314 | $90,998 | $63,584 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,854 | 2,334 | 2,331 | 1,894 | 340 |
| Common Shares | 4 | 17 | 17 | 6 | 1 |
| Retained earnings | -566,196 | -543,015 | -518,301 | -350,861 | -310,587 |
| Other shareholders' equity | 0 | 0 | 0 | -40 | 5 |
| TOTAL | $37,493 | $49,516 | $71,528 | $69,535 | $17,575 |
| Total Liabilities And Equity | $93,742 | $107,683 | $130,842 | $160,533 | $81,159 |